According to Aipeng Medical's announcement, the cumulative deviation value of the company's stock price increase exceeded 30% for two consecutive trading days from July 27 to 28, 2026, which was an abnormal fluctuation. After verification, there is no need to correct or supplement the information previously disclosed by the company. Recently, the operation is normal, the internal and external environment has not changed, the company, controlling shareholders and actual controllers should not disclose important matters that have not been disclosed, and the actual controller did not trade the company's shares during this period. The company's 2026 semi-annual report will be disclosed on August 26.

According to Aipeng Medical's announcement, the cumulative deviation value of the company's stock price increase exceeded 30% for two consecutive trading days from July 27 to 28, 2026, which was an abnormal fluctuation. After verification, there is no need to correct or supplement the information previously disclosed by the company. Recently, the operation is normal, the internal and external environment has not changed, the company, controlling shareholders and actual controllers should not disclose important matters that have not been disclosed, and the actual controller did not trade the company's shares during this period. The company's 2026 semi-annual report will be disclosed on August 26.